Adverse Event Clinical Research R4 Backport
1.0.1 - STU1 International flag

Adverse Event Clinical Research R4 Backport, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-backport-ig/ and changes regularly. See the Directory of published versions

: medication-request-example-tucatinib - XML Representation

Page standards status: Informative

Raw xml | Download



<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="medication-request-example-tucatinib"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="medication-request-example-tucatinib"> </a><a name="hcmedication-request-example-tucatinib"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest &quot;medication-request-example-tucatinib&quot; </p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: tucatinib 150 MG Oral Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#2361290)</span></p><p><b>subject</b>: <a href="Patient-patient-example-kaitlyn-b.html">Patient/patient-example-kaitlyn-b</a> &quot; BOUNCE&quot;</p><p><b>authoredOn</b>: 2020-03-12</p><p><b>requester</b>: <a href="Practitioner-practitioner-owen-oncologist.html">Practitioner/practitioner-owen-oncologist</a> &quot; ONCOLOGIST&quot;</p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: oral twice a day every day</p><p><b>timing</b>: Starting 2020-04-01, Once</p><p><b>route</b>: Oral route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><p><b>maxDosePerAdministration</b>: 2</p></blockquote></div>
  </text>
  <status value="active"/>
  <intent value="order"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <code value="2361290"/>
      <display value="tucatinib 150 MG Oral Tablet"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/patient-example-kaitlyn-b"/>
  </subject>
  <authoredOn value="2020-03-12"/>
  <requester>🔗 
    <reference value="Practitioner/practitioner-owen-oncologist"/>
  </requester>
  <dosageInstruction>
    <text value="oral twice a day every day"/>
    <timing>
      <repeat>
        <boundsPeriod>
          <start value="2020-04-01"/>
        </boundsPeriod>
      </repeat>
    </timing>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="26643006"/>
        <display value="Oral route (qualifier value)"/>
      </coding>
    </route>
    <doseAndRate>
      <rateQuantity>
        <value value="150"/>
        <unit value="MG"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="MG"/>
      </rateQuantity>
    </doseAndRate>
    <maxDosePerAdministration>
      <value value="2"/>
    </maxDosePerAdministration>
  </dosageInstruction>
</MedicationRequest>